• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动静脉内瘘的经皮血栓切除术:即刻成功率和长期通畅率

Percutaneous thrombectomy of AVF: immediate success and long-term patency rates.

作者信息

Nassar George M, Rhee Edward, Khan Abdul Jabbar, Nguyen Binh, Achkar Katafan, Beathard Gerald

机构信息

Dialysis Access Management Centers, Nephrology Dialysis and Transplantation Associates, The Kidney Institute & Houston Methodist Hospital, Weill Cornell University, Houston, Texas.

出版信息

Semin Dial. 2015 Mar-Apr;28(2):E15-22. doi: 10.1111/sdi.12336. Epub 2014 Dec 22.

DOI:10.1111/sdi.12336
PMID:25533577
Abstract

The purpose of this study was to report the results obtained in a cohort of 520 cases of thrombosed arteriovenous fistulas (AVF) treated by percutaneous intervention over a period of 8 years. The methods used varied according to the individual characteristics of the case. A clinical success rate of 91.1% was obtained with no significant difference being noted among radial-cephalic, brachial-cephalic, and brachial-basilic AVFs. The mean primary patency for this group was 227.3 ± 14.6 days, and the mean assisted primary patency was 677.2 ± 44.6 days. The lower arm AVFs had both a primary patency and an assisted primary patency that were significantly better than the upper arm cases (p = 0.006 and 0.002, respectively). The primary patency for radial-cephalic AVFs was significantly better than that for brachial-cephalic AVFs (p = 0.021), but not for brachial-basilic cases (p = 0.122). Assisted primary patency for radial-cephalic cases was significantly superior to the values for either patients with a brachial cephalic (p = 0.046) or a brachial-basilic (p = 0.004). Complications occurred in seven cases (1.3%), all of which were venous ruptures. Blood flow was affected in four cases. Only one of these was salvaged with angioplasty balloon tamponade. In the remaining three cases, the AVF was lost.

摘要

本研究的目的是报告一组520例血栓形成的动静脉内瘘(AVF)患者在8年期间接受经皮介入治疗所取得的结果。所采用的方法根据病例的个体特征而有所不同。临床成功率为91.1%,桡动脉-头静脉、肱动脉-头静脉和肱动脉-尺静脉动静脉内瘘之间未观察到显著差异。该组的平均初次通畅时间为227.3±14.6天,平均辅助初次通畅时间为677.2±44.6天。前臂动静脉内瘘的初次通畅率和辅助初次通畅率均显著优于上臂病例(分别为p = 0.006和0.002)。桡动脉-头静脉动静脉内瘘的初次通畅率显著优于肱动脉-头静脉动静脉内瘘(p = 0.021),但与肱动脉-尺静脉病例相比无显著差异(p = 0.122)。桡动脉-头静脉病例的辅助初次通畅率显著高于肱动脉-头静脉(p = 0.046)或肱动脉-尺静脉(p = 0.004)患者。7例(1.3%)发生并发症,均为静脉破裂。4例血流受到影响。其中只有1例通过血管成形术球囊压迫得以挽救。其余3例动静脉内瘘失功。

相似文献

1
Percutaneous thrombectomy of AVF: immediate success and long-term patency rates.动静脉内瘘的经皮血栓切除术:即刻成功率和长期通畅率
Semin Dial. 2015 Mar-Apr;28(2):E15-22. doi: 10.1111/sdi.12336. Epub 2014 Dec 22.
2
Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.通过积极的通路监测和血管内治疗,上肢Vectra血管通路移植物与转位肱动脉-贵要静脉内瘘的等效二级通畅率。
J Vasc Surg. 2008 Feb;47(2):407-14. doi: 10.1016/j.jvs.2007.09.061. Epub 2007 Dec 26.
3
The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery.实施优化护理方案对动静脉血液透析通路手术结局的影响。
J Vasc Surg. 2008 Sep;48(3):659-68. doi: 10.1016/j.jvs.2008.04.002. Epub 2008 Jun 24.
4
Impact of reintervention for failing upper-extremity arteriovenous autogenous access for hemodialysis.对失败的上肢自体动静脉血液透析通路进行再次干预的影响。
J Vasc Surg. 2001 Dec;34(6):1004-9. doi: 10.1067/mva.2001.119750.
5
Results of repeated percutaneous interventions on failing arteriovenous fistulas and grafts and factors affecting outcomes.对功能衰竭的动静脉内瘘和移植物进行重复经皮介入治疗的结果及影响预后的因素。
J Vasc Surg. 2016 Mar;63(3):772-7. doi: 10.1016/j.jvs.2015.09.031. Epub 2015 Nov 17.
6
Brachial vein transposition arteriovenous fistula: is it an acceptable option for chronic dialysis vascular access?肱静脉转位动静脉内瘘:它是慢性透析血管通路的一个可接受的选择吗?
J Vasc Access. 2008 Jan-Mar;9(1):39-44.
7
Percutaneous rheolytic thrombectomy of thrombosed autogenous dialysis fistulas: technical results, clinical outcome, and factors influencing patency.自体动静脉内瘘血栓形成的经皮腔内超声消融血栓切除术:技术结果、临床结局及影响通畅率的因素
J Endovasc Ther. 2015 Feb;22(1):80-6. doi: 10.1177/1526602814566378.
8
Comparison of Ellipsys Percutaneous and Proximal Forearm Gracz-Type Surgical Arteriovenous Fistulas.Ellipsys经皮与前臂近端Gracz型手术动静脉内瘘的比较
Am J Kidney Dis. 2021 Oct;78(4):520-529.e1. doi: 10.1053/j.ajkd.2021.01.011. Epub 2021 Mar 1.
9
Secondary patency of thrombosed prosthetic vascular access grafts with aggressive surveillance, monitoring and endovascular management.通过积极监测、监控和血管内管理实现血栓形成的人工血管通路移植物的二期通畅。
Eur J Vasc Endovasc Surg. 2008 Sep;36(3):356-65. doi: 10.1016/j.ejvs.2008.05.007. Epub 2008 Jul 7.
10
Endovascular treatment of immature, dysfunctional and thrombosed forearm autogenous ulnar-basilic and radial-basilic fistulas for haemodialysis.血管内治疗不成熟、功能不良和血栓形成的前臂自体尺桡侧头静脉和桡侧头静脉内瘘用于血液透析。
Nephrol Dial Transplant. 2010 Feb;25(2):532-8. doi: 10.1093/ndt/gfp467. Epub 2009 Sep 11.

引用本文的文献

1
The Delay of Recanalisation of Acutely Thrombosed Dialysis Arteriovenous Access Until the Next Workday has No Negative Impact on Clinical Outcome.急性血栓形成的透析动静脉通路再通延迟至下一个工作日对临床结局无负面影响。
Cardiovasc Intervent Radiol. 2025 Apr;48(4):450-457. doi: 10.1007/s00270-024-03897-5. Epub 2024 Nov 18.
2
Thrombectomy approach for access maintenance in the end stage renal disease population: a narrative review.终末期肾病患者血管通路维护的血栓切除术方法:一篇叙述性综述
Cardiovasc Diagn Ther. 2023 Feb 28;13(1):265-280. doi: 10.21037/cdt-21-523. Epub 2021 Dec 28.
3
Salvage of thrombosed arteriovenous fistulae of patients on hemodialysis: report on the experience of a Brazilian center.
血液透析患者血栓形成的动静脉内瘘挽救:巴西一家中心的经验报告。
J Bras Nefrol. 2018 Oct-Dec;40(4):351-359. doi: 10.1590/2175-8239-jbn-2018-0036. Epub 2018 Aug 30.